Dyslipidemia in systemic lupus erythematosus: just another comorbidity?

K Tselios, C Koumaras, DD Gladman… - Seminars in arthritis and …, 2016 - Elsevier
Objective Among traditional atherosclerotic risk factors, dyslipidemia is believed to
decisively affect the long-term prognosis of lupus patients, not only with regard to …

Correlation between chest computed tomography and lung ultrasonography in patients with coronavirus disease 2019 (COVID-19)

Y Tung-Chen, MM de Gracia, A Díez-Tascón… - Ultrasound in medicine …, 2020 - Elsevier
There is growing evidence regarding chest X-ray and computed tomography (CT) findings
for coronavirus disease 2019 (COVID-19). At present, the role of lung ultrasonography (LUS) …

Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis

N Bello, KJ Meyers, J Workman, L Hartley… - Lupus, 2023 - journals.sagepub.com
Background Systemic lupus erythematosus (SLE) is an autoimmune disease that typically
affects women aged 16–55 years. Cardiovascular disease (CVD) is a well-recognized …

Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: a systematic review

K Tselios, BJ Sheane, DD Gladman… - The Journal of …, 2016 - jrheum.org
Objective. Premature coronary heart disease (CHD) significantly affects morbidity and
mortality in systemic lupus erythematosus (SLE). Several studies have detected factors …

[HTML][HTML] Factors associated with cardiovascular events in systemic lupus erythematosus in a monocentric cohort with up to 40 years of follow-up

N Farina, J Webster, W Luo, D Garelick… - Seminars in Arthritis and …, 2023 - Elsevier
Objectives Systemic lupus erythematosus (SLE) is associated with an increased
cardiovascular risk. Several traditional and disease-specific risk factors have been shown to …

Cardiovascular disease in lupus: insights and updates

JS Knight, MJ Kaplan - Current opinion in rheumatology, 2013 - journals.lww.com
CVD is a major complication of lupus and is now a leading cause of death among people
living with this disease. As such, additional studies are needed in order to identify the most …

Evolution of risk factors for atherosclerotic cardiovascular events in systemic lupus erythematosus: a longterm prospective study

K Tselios, DD Gladman, J Su, O Ace… - The Journal of …, 2017 - jrheum.org
Objective. We previously reported the effect of certain factors on cardiovascular disease
(CVD) in 250 women with systemic lupus erythematosus (SLE) followed for 8 years. The aim …

The impact of obesity on SLE disease activity: findings from the Southern California Lupus Registry (SCOLR)

P Teh, B Zakhary, VK Sandhu - Clinical Rheumatology, 2019 - Springer
The role of obesity in systemic lupus erythematosus (SLE) remains controversial. Studies
have linked adiposity with a heightened risk of clinical complications including …

Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus …

K Tselios, DD Gladman, J Su, M Urowitz - Annals of the Rheumatic …, 2020 - ard.bmj.com
Background The 2017 American College of Cardiology/American Heart Association
guidelines defined hypertension at≥ 130/80 mm Hg. Studies on patients with connective …

The evolving concept of SLE comorbidities

LA González, GS Alarcon - Expert review of clinical immunology, 2017 - Taylor & Francis
Introduction: The survival of SLE patients has improved significantly over the past few
decades placing them at increased risk of cardiovascular disease (CVD), malignancies, and …